Caris Life Sciences, Inc. (CAI)
26.13
-0.14
(-0.53%)
USD |
NASDAQ |
Aug 24, 16:00
26.12
0.00 (0.00%)
After-Hours: 20:00
Caris Life Sciences Shareholders Equity (Quarterly) : 591.73M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 591.73M |
| March 31, 2026 | 593.49M |
| December 31, 2025 | 577.31M |
| September 30, 2025 | 478.36M |
| Date | Value |
|---|---|
| June 30, 2025 | 452.90M |
| March 31, 2025 | -353.75M |
| December 31, 2024 | -277.19M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| CareDx, Inc. | 425.60M |
| Myriad Genetics, Inc. | 303.90M |
| BioRestorative Therapies, Inc. | 3.026M |
| Natera, Inc. | 1.821B |
| Exagen, Inc. | 12.22M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.230B |
| Total Liabilities (Quarterly) | 637.89M |
| Debt to Equity Ratio | 0.7645 |
| Current Ratio | 5.526 |
| Net Debt Paydown Yield | -0.13% |